Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Molecules ; 25(1)2019 Dec 18.
Artigo em Inglês | MEDLINE | ID: mdl-31861277

RESUMO

Soon after they were first described in 1990, aptamers were largely recognized as a new class of biological ligands that can rival antibodies in various analytical, diagnostic, and therapeutic applications. Aptamers are short single-stranded RNA or DNA oligonucleotides capable of folding into complex 3D structures, enabling them to bind to a large variety of targets ranging from small ions to an entire organism. Their high binding specificity and affinity make them comparable to antibodies, but they are superior regarding a longer shelf life, simple production and chemical modification, in addition to low toxicity and immunogenicity. In the past three decades, aptamers have been used in a plethora of therapeutics and drug delivery systems that involve innovative delivery mechanisms and carrying various types of drug cargos. However, the successful translation of aptamer research from bench to bedside has been challenged by several limitations that slow down the realization of promising aptamer applications as therapeutics at the clinical level. The main limitations include the susceptibility to degradation by nucleases, fast renal clearance, low thermal stability, and the limited functional group diversity. The solution to overcome such limitations lies in the chemistry of aptamers. The current review will focus on the recent arts of aptamer chemistry that have been evolved to refine the pharmacological properties of aptamers. Moreover, this review will analyze the advantages and disadvantages of such chemical modifications and how they impact the pharmacological properties of aptamers. Finally, this review will summarize the conjugation strategies of aptamers to nanocarriers for developing targeted drug delivery systems.


Assuntos
Aptâmeros de Nucleotídeos/química , Fenômenos Químicos , Portadores de Fármacos/química , Sistemas de Liberação de Medicamentos , Humanos , Imunoconjugados/química , Ligantes , Lipídeos/química , Estrutura Molecular , Nanopartículas/química , Técnica de Seleção de Aptâmeros
2.
Materials (Basel) ; 14(21)2021 Nov 04.
Artigo em Inglês | MEDLINE | ID: mdl-34772163

RESUMO

Olive oil production generates solid and liquid wastes that cause various environmental problems due to their high phenols and polyphenols load. Although many treatment methods were investigated to manage these wastes, more research is still needed to identify simple and cost-effective approaches. In this study, activated carbon (AC) was prepared from olive cake waste and functionalized with Cu/Cu2O/CuO for efficient and selective removal of phenolic content from olive mill wastewater (OMW). AC media were characterized by scanning electron/dispersive X-ray spectroscopy (SEM-EDS), X-ray diffraction (XRD), Fourier transform infrared (FTIR) spectrometry, and Brunauer-Emmett-Teller (BET) surface area analysis. The optimum adsorption parameters were investigated, and the adsorption isotherms, thermodynamics, and kinetics were determined. The adsorption of phenols onto copper oxide AC was best described by the Langmuir adsorption with maximum adsorption capacity of 13.9, 12.7, and 9.9 mg/g at 311, 302, and 293 K, respectively. The adsorption reaction was found to be spontaneous and endothermic where ∆H° and ∆G° were found to be 30.104 kJ/mol and -1.765, -2.839, and -3.723 (kJ/mol) at 311, 302, and 293 K, respectively. In addition, the kinetics data were perfectly fit by the pseudo-second-order model. The activated product derived from recyclable olive cake and enriched with inorganic functionality can offer a cost-effective treatment solution for OMW; thus, reducing both the liquid and solid waste generated from the olive mill industry.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA